DEPIPZO

Mark For: DEPIPZO® trademark registration is intended to cover the categories of pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; multivitamins preparations; pharmaceutical preparations for diagnosis for medical or veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics. [all]

Research	OneLook Acronym Finder
Serial Number	87900863
Registration Number	5779008
Mark Literal Elements	DEPIPZO
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2019-06-18
Basis	44(e)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	Yes
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Miriam D. Trudell
Attorney Name	Miriam D. Trudell
Attorney Docket Number	5413CMG-1
Law Office Assigned	L40
Employee Name	FATHY, DOMINIC

Timeline

2018-04-30	Application Filed
2019-04-02	Published
2019-04-02	Published for Opposition
2019-06-18	Location: PUBLICATION AND ISSUE SECTION
2019-06-18	Status: Live/Registered
2019-06-18	Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-06-18	Trademark Registered
2019-06-18	Transaction Date
2024-06-18	Maintenance Early File Date
2025-06-18	Maintenance On Time Date
2025-12-18	Maintenance Late Fee Date

Party:	CMG Pharmaceutical Co.,Ltd.
Address	14, Dosan-daero 66-gil Gangnam-gu, Seoul KOREA, REPUBLIC OF
Legal Entity Type	Corporation
Legal Entity State	KOREA, REPUBLIC OF

Drawing	JPEG	2018-04-30
TEAS RF New Application	MULTI	2018-04-30
Offc Action Outgoing	XML	2018-08-21
XSearch Search Summary	XML	2018-08-21
Response to Office Action	MULTI	2019-02-07
Amendment and Mail Process Complete	MULTI	2019-02-20
Amendment to Delete or Correct Basis	MULTI	2019-02-20
TRAM Snapshot of App at Pub for Oppostn	MULTI	2019-02-21
Notice of Publication	XML	2019-03-13
Notification Of Notice of Publication	XML	2019-03-13
OG Publication Confirmation	XML	2019-04-02
Registration Certificate	PDF	2019-06-18

MIRIAM D. TRUDELL
SHERIDAN ROSS P.C.
1560 BROADWAY, SUITE 1200
DENVER, CO 80202

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; multivitamins preparations; pharmaceutical preparations for diagnosis for medical or veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; multivitamins preparations; pharmaceutical preparations for diagnosis for medical or veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics
GS0051	Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; multivitamins preparations; pharmaceutical preparations for diagnosis for medical or veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics

Description	Date	Proceeding Number
REGISTERED-PRINCIPAL REGISTER	2019-06-18
PUBLISHED FOR OPPOSITION	2019-04-02
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-04-02
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-03-13
ELECTRONIC RECORD REVIEW COMPLETE	2019-02-26	73793
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED	2019-02-22
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-02-20
TEAS/EMAIL CORRESPONDENCE ENTERED	2019-02-19	68171
CORRESPONDENCE RECEIVED IN LAW OFFICE	2019-02-19	68171
ASSIGNED TO LIE	2019-02-13	68171
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2019-02-07
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2018-08-21	6325
NON-FINAL ACTION WRITTEN	2018-08-21	81854
NON-FINAL ACTION E-MAILED	2018-08-21	6325
ASSIGNED TO EXAMINER	2018-08-21	81854
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-05-09
NEW APPLICATION ENTERED IN TRAM	2018-05-03